12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Harpoon Therapeutics (NASDAQ:HARP) stock increased by 110.9% to $22.25 during Monday’s pre-market session. The company’s market cap…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Heart Test Laboratories (NASDAQ:HSCS) stock moved upwards by 41.6% to $0.23 during Friday’s after-market session. The market…
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Applied Therapeutics, Inc.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Ainos (NASDAQ:AIMD) stock moved upwards by 74.0% to $3.01 during Friday’s regular session. The market value of…
US Stocks Higher; Payrolls Increase By 216,000 In December
U.S. stocks traded higher this morning, following the release of jobs data on Friday.
Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40. The S&P 500 also rose, gaining, 0.21% to 4,698.40.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Ainos (NASDAQ:AIMD) shares rose 150.3% to $4.33 during Friday’s pre-market session. The company’s market cap stands at…
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.
Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Biomerica (NASDAQ:BMRA) shares rose 54.5% to $1.53 during Tuesday’s pre-market session. The market value of their outstanding…
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.